Hook + thesis
RTX Corporation sits squarely in a favorable spot for a mid-term trade: defense order flow is surging while the commercial engine cycle shows tentative recovery. Recent geopolitical shocks and inventory replenishment needs have pushed defense demand into the front seat, offering an earnings and cash-flow tailwind that can offset near-term cyclicality at Pratt & Whitney.
My trade thesis is simple and actionable: buy RTX at market (current $177.04) with a mid-term horizon of 45 trading days, targeting a bounce to $205 and a protective stop at $165. The rationale is a combination of strong free cash generation ($8.46B), a healthy balance sheet (debt/equity ~0.56), and visible defense catalysts that can re-rate sentiment and push the stock back toward the 52-week high region if order momentum continues.
What RTX does and why the market should care
RTX is a diversified aerospace and defense conglomerate operating four businesses: Collins Aerospace, Pratt & Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). That mix gives RTX a dual-cycle profile. Pratt & Whitney is exposed to the commercial aerospace cycle — passenger traffic and OEM production rates — while RIS and RMD are directly tied to defense budgets, replenishment, and urgent program spending.
The market cares because defense demand has become more front-loaded in 2026. Recent reports (05/24/2026 and through mid-May) describe U.S. and allied replenishment needs after the Iran conflict and additional missile purchases from partners like Qatar. Large replenishment orders and potential new programs tied to missile defense spending can disproportionately lift margins in RMD and RIS — parts of RTX with higher defense content and attractive incremental margins.
Support for the argument - the numbers
- Market cap sits at roughly $238.4B with enterprise value near $268.97B.
- Reported earnings per share are around $5.39, implying a P/E of ~33x. That multiple is rich versus historical aerospace averages but reflects steady cash flow and defense backlog visibility.
- Free cash flow is meaningful at $8.457B, and return on equity is a respectable 10.95%.
- Balance sheet metrics are solid: debt-to-equity around 0.56, current ratio ~1.02, quick ratio ~0.78. Those ratios give RTX flexibility to fund working capital and capture urgent defense work.
- Technicals show a short-term consolidation: the 10-day SMA is $176.07, 20-day SMA is $175.40, while the 50-day SMA sits higher at $187.59. MACD shows bullish momentum with a positive histogram, but RSI is neutral at ~45, leaving room to run before overbought conditions set in.
Valuation framing
At roughly 33x reported EPS and an EV/EBITDA near 19.9x, RTX trades at a premium to broad industrials but closer to peers in the defense-oriented segment where multiples are often elevated due to backlog visibility and recurring government demand. Put differently, the market is pricing in continued margin and cash-flow stability. The single-year P/E looks full, but two mitigating factors support a re-rating argument:
- Substantial free cash flow of $8.46B supports dividend and buyback optionality or accelerated debt paydown, which can lift per-share metrics.
- Defense order acceleration and program wins (Patriot/PAC deals and missile replenishment) can add high-margin revenue with limited incremental capital needs, improving EBITDA and justifying a higher multiple.
Catalysts (what to watch)
- Near-term defense contract awards and replenishment announcements (sales to Gulf partners, NATO commitments) that translate into visible RMD/RIS backlog growth.
- Quarterly results and guideposts that show stabilization or improvement at Pratt & Whitney — even modest recovery in OEM production rates can materially impact revenue and sentiment.
- Any major program funding from the Pentagon related to missile defense (